Notables in Research, Health Care and Philanthropy to Serve as Judges for First Annual Biotech Humanitarian Award
April 15, 2009 - WASHINGTON, D.C. - The Biotechnology Industry Organization (BIO) announced that a distinguished panel of judges will evaluate nominations for the first annual Biotech Humanitarian Award. BIO established the Award to recognize everyday heroes within the biotechnology community who have helped heal, fuel and feed the planet through their work in biotech, and to honor one contributor as the 2009 Biotech Humanitarian of the year.
An impressive group of leaders in science, policy, business and philanthropy have agreed to serve as judges for the Award:
- Dr. David Agus - Professor of Medicine, Director, Center for Applied Molecular Medicine and Westside Cancer Center, University of Southern California
- Dr. Anna Barker - Deputy Director, National Cancer Institute and Deputy Director for Strategic Scientific Initiatives
- Dr. Joshua Boger - Founder and CEO, Vertex Pharmaceuticals
- Dr. Jessie Gruman - President, Center for Advancing Health
- Phil Hills - Executive Vice President, Lance Armstrong Foundation
- Katie Hood - CEO, The Michael J. Fox Foundation for Parkinson’s Research
- Catherine Ivy - Founder and Board President, the Ben and Catherine Ivy Foundation
- Dr. Evelyn Lewis - Executive Medical Director, Uniformed Services University Center for Health Disparities Education and Research
- Richard Pops - Chairman, Board of Directors, Alkermes
I am honored to be joined by such luminaries in the field of research, advocacy, philanthropy and policy as we work to select the inaugural honoree of the Biotech Humanitarian Award. We know it will be difficult to select a winner amongst the impressive group of nominees we have received, but we are thrilled to have the privilege to work together and select the 2009 Biotech Humanitarian," said Jim Greenwood, BIO President and CEO.
The Biotech Humanitarian Award and the $10,000 prize will be bestowed on the winner on May 20, 2009 at the 2009 BIO International Convention in Atlanta, GA. Nominations can be made until 11:59 pm Eastern on April 15, 2009 via www.iambiotech.org.
"Biotechnology is fueling transformations in the medical, industrial and agricultural fields, but too often much of the critical work happens out of the public eye," said Dr. Joshua Boger, Chairman of BIO’s Board of Directors and CEO of Vertex Pharmaceuticals Incorporated. "The Biotech Humanitarian Award is one way our innovative industry will shine a spotlight on the top biotech contributions that have improved contemporary society."
Upcoming BIO Events
BIO-LES Business Development Basics Course
May 15–17, 2009
BIO-LES Advanced Business Development Course
May 15–17, 2009
BIO Executive Presentation Workshop
May 17, 2009
BIO Human Resources Conference
May 17-19, 2009
2009 BIO International Convention
May 18-21, 2009
June 9-10, 2009
World Congress on Industrial Biotechnology & Bioprocessing
July 19-22, 2009
Montreal, Quebec, Canada
BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.